Spica Therapeutics | Valuation, Funding Rounds & Stock Price | Caplight

Spica Therapeutics

Private
Antwerp
Healthcare & Life Sciences
Spica Therapeutics Website

Last Round: Grant
Date: Aug 27, 2025
Total Funding Raised: $12.54M
Momentum: Top 50% of companies Caplight tracks

Company Overview

Spica Therapeutics is a biotechnology company that develops macrophage-subset targeted therapies using a proprietary functional fingerprinting platform to address oncology and fibroinflammatory diseases.

Sector: Healthcare & Life Sciences
Verticals: Biotechnology, Drug Discovery, Precision Medicine
Business Model: B2B
Customer Profile: Services & Consulting
AI Layer: Non-AI
Keywords: biotechnology, drug discovery, macrophage therapy, oncology, precision medicine, fibroinflammatory disease, autoimmune disease, antibody development, targeted therapy, biotech startup, preclinical research, drug pipeline, therapeutics, biopharma

Spica Therapeutics Comparables

Compare Spica Therapeutics with similar companies based on industry and business-model similarity.

Company Similarity Market Cap
Macomics 87% N/A
DEM BioPharma 79% N/A
Resolute Science 79% N/A
Comparable company 50% N/A

Spica Therapeutics Funding Rounds

Historical fundraising activity.

Round Date Amount Raised Valuation Investors
Grant Aug 27, 2025 N/A N/A N/A
Seed Jun 4, 2025 N/A N/A N/A

Spica Therapeutics Investors

Notable investors and investment history.

Investor Rounds
VLAIO Grant
Bioqube Ventures Seed
PMV Seed

Market Signals

Structured signals derived from secondary market and firmographic data.

Spica Therapeutics Filings

SEC and related filings with document metadata.

Typed Date Amount Offered Amount Sold
Mock Valuation Sign Up to view Mock Valuation Sign Up to view
Mock Valuation Sign Up to view Mock Valuation Sign Up to view
Mock Valuation Sign Up to view Mock Valuation Sign Up to view
Mock Valuation Sign Up to view Mock Valuation Sign Up to view

Frequently Asked Questions

Common questions about Spica Therapeutics's valuation, stock price, and market status.

Firmographic Details

Headquarters: Antwerp
Employee Range: 16
Year Founded: 2024
Last Funding: Aug 27, 2025